Immupharma steadfast in belief Lupuzor has commercial merit
Lupuzor did work well in certain patients, chiefly those who were antibody-positive
Company
ImmuPharma PLC
LON:IMM
ImmuPharma PLC is a biopharmaceutical company that specializes in the usage and development of biopolymers, specifically peptides. The company is dedicated to developing an innovative portfolio of peptide-based therapeutic drugs with a focus on autoimmunity/inflammation and anti-infectives.
305 stories · page 2 of 4
ImmuPharma targets regulatory approval as follow-up study confirms “outstanding” safety profile of Lupuzor
The drug developer also recently raised £2.66mln from its institutional investor, Lanstead Capital, to help execute its corporate strategy
Archive
Proactive news snapshot: Seeing Machines, Xpediator, Physiomics...
A glance at some of the day's highlights from the Proactive Investors newswire
VR group Immotion flags strategy shift as it focuses on long-term partnerships
In future, the focus will be on revenue sharing partnerships to roll-out its virtual reality pods into high footfall locations
Investments and investor services
FTSE 100 closes lower but BP top gainer after Q2 results beat expectations
The FTSE 100 index closed 39.84 points lower on the day at 7,646, while the midcap FTSE 250 index plunged almost 112 points to close at 19,774
Archive
Proactive news snapshot: Union Jack Oil, Oncimmune, Ariana Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Angus Energy considers sale of Brockham licences after disappointing drilling programme
A look at the day's major movers, including Rose Petroleum, Craneware, CVS, Adept4, Merlin, Mirriad and Costain
ImmuPharma jumps as follow-up study confirms safety of flagship lupus drug
After Lupuzor missed its primary endpoint in a phase III trial last year, ImmuPharma has been working hard to build a data package for the drug which it can take to regulators
Investments and investor services
FTSE 100 closes higher on day and week as world leaders meet
The mid-cap FTSE 250 added over 147 points to close at 19,462 on Friday
Archive
Serco's acquisitions and contract wins will be in focus on Thursday
Serco has already flagged that it expects its strong order intake to boost revenue in 2019 after several years of declines.
Archive
Proactive news snapshot: 88 Energy, Tekcapital, AFC Energy, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Kibo Energy the day's top riser as its moves to secure total ownership of the Bordersley project
A look at the day's major movers, including 88 Energy, Two Shields, Inland Homes, Avingtrans, Creightons, RM2 and RPS Group
ImmuPharma raises around £2.66mln from subscription agreement with institutional investor, Lanstead Capital
It said the proceeds of the subscription will be used primarily to fund the execution of its corporate strategy, including progressing Lupuzor through both corporate partnerships and regulatory pathways
Archive
FTSE 100 still stuck in neutral; G20 meeting can't come soon enough
Bitcoin is up more than 10% but the shine has come off gold a bit
Archive
News from FirstGroup, Stagecoach to drive corporate diary in coming week
Aside from the two mid-cap transport operators, blue chip contractor Bunzl will also issue a trading update, while the macro focus will be on the G20 meeting in Japan
Archive
Proactive news snapshot: Strategic Minerals, Westminster Group, Victoria Oil & Gas, ImmuPharma …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Royal Mail rises after stamp of approval from Liberum
A look at the day's major movers, including Headlam, Old Mutual, Caledonian Trust, Westminster Group, Luceco, Strategic Minerals, Tarsus and Mothercare
ImmuPharma continuing to talk with potential partners
The drug developer is assessing the best route forward for its lead drug, a treatment for the autoimmune disease, Lupus
Investments and investor services
Thomas Cook slumps again as debt-for-equity swap or emergency rights issue is expected
A look at the day's major movers, including Future, Capital & Regional, Tiger Resource, Metro Bank, eve Sleep, Maistro and Staffline
Archive
Proactive news snapshot: Alba Mineral Resources, Immotion Group, Pan African Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Kromek, ITM Power, Rockfire Resources
A glance at some of the day's highlights from the Proactive Investors newswire
ImmuPharma updates status of talks over lead drug alongside reorganisation
The firm remains in conversation with potential commercial partners as well as its regulatory advisors
Investments and investor services
System1 Group pulls out of tailspin
A look at the day's major movers, including Energean Oil and Gas, Kier Group, Spectra Systems, Mayan Energy, Ascent Resources and Emmerson
Archive
Proactive news snapshot: SigmaRoc, Summit Therapeutics, Immotion Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Immotion to install its virtual reality pods at two major US aquariums
Immotion will install a range of VR cinematic motion pods on a revenue-share basis at Odysea Aquarium, in Scottsdale, Arizona, and The Maritime Aquarium, in Norwalk, Connecticut
Investments and investor services
FTSE 100 closes flat as traders don't know which way to turn
Footsie closed down around 0.19 at 7,436, while mid-cap FTSE 250 was up around 95 points at 19,807
Investments and investor services
Versarien boosted by completion of Graphene Council's "Verified Graphene Producer" programme
A look at the day's major movers, including Edenville Energy, Beowulf, Panthera Resources, Management Resource Solutions, Independent Oil & Gas, Block Energy, Highlands Natural Resources and Reabold Resources
Archive
Proactive news snapshot: Iofina, Circassia Pharma, Directa Plus, Instem …
A glance at some of the day's highlights from the Proactive Investors newswire
ImmuPharma cancer programme talks continue
Conversations with Incanthera are continuing even though an extended period of exclusivity has lapsed
Archive
Proactive news snapshot: NetScientific, Capital Drilling, Horizonte Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
RedT Energy Storage shares plunge as it announces strategic review and equity raise
A look at some of the top risers and fallers in London on Thursday.
ImmuPharma continues to engage with potential corporate partners for Lupuzor, its late-stage treatment for Lupus
The firm said that following the conclusion of the pivotal Phase III trial earlier in 2018, it continues to look at opportunities which, over the longer term, have the potential of bringing Lupuzor to market
Archive
FTSE 100 closes higher as no deal Brexit fears ease
Footsie closed around 26 points higher at 7,185, while FTSE 250 added around 103 points at 19,283
XLMedia and Serinus Energy among Tuesday’s small-cap losers
A look at the day's major movers, including Persimmon, Quadrise Fuels International, Travis Perkins, and Babcock
Archive
Proactive news snapshot: Amur Minerals, Ormonde Mining, Europa Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
ImmuPharma says article shines light on potential of peptide subsidiary
Peptide drugs generated US$30bn in sales last year
FTSE 100 closes lower as Brexit is talk of the town
Footsie closed down around 32 points at 7,151, while the FTSE 250 added 23 at 19,270
ImmuPharma continues to build data package for flagship lupus treatment
Results from a 62-patient follow-up study are due shortly, while data from a 500-person-strong managed access programme should be available by the end of next year
Archive
Proactive news snapshot: ImmuPharma, Eurasia Mining, Tower Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
ImmuPharma says managed access programme for Lupozor progressing as planned
The AIM-listed firm said that following analysis of the regulatory processes in EU countries, it is planned to begin patient recruitment for the programme in France and UK
Archive
Proactive news snapshot: Tower Resources, MySQUAR, Kore Potash …
A glance at some of the day's highlights from the Proactive Investors newswire
Sure Ventures pleased with progress of tech investments this year
“We are especially pleased with the successful IPO of our first direct investment, Immotion PLC, that came to fruition just a short few months after cash deployment”
Archive
Proactive news snapshot: Amryt Pharma, Directa Plus, Live Company...
A glance at some of the day's highlights from the Proactive Investors newswire
ImmuPharma boss excited by “blockbuster potential” of Lupuzor
The lupus treatment missed its primary endpoint in a phase III study earlier this year, but ImmuPharma CEO Tim McCarthy still has high hopes for the drug
Managed access programmes offer an alternative way forward for drug companies
Eighteen of the top 20 big pharmaceutical companies now provide early access to their drugs
Archive
Proactive news snapshot: Pan African Resources, Strategic Minerals, Strategic Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Mission Marketing Group shares step up, United Carpets declines
A look at some of the biggest risers and fallers in the UK market on Wednesday
Investments and investor services
FTSE 100 closes higher as trade fears ebb; Kingfisher leads the laggards
The FTSE 100 closed nearly 31 points higher at 7,331, while FTSE 250 added over 42 at 20,500
Archive
Proactive news snapshot: Echo Energy, Pan African Resources, Chagala Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Airlines under pressure after IAG's British Airways unit hit by data theft
A look at some of the biggest risers and fallers in the London market on Friday
ImmuPharma’s flagship lupus drug to be made available to patients ahead of regulatory filing
Normally, patients have to wait until regulators have approved a drug before they get access to it, but up to 500 lupus sufferers will receive Lupuzor as part of a Managed Access Programme
FTSE 100 takes a dive again; miners bear brunt
FTSE 100 finished down around 41 points or 0.56%, at 7,277 as its poor run continues
EQTEC surges on new €22mln contract win
Some of the main news-driven risers and fallers in London on Thursday afternoon...
Archive
Proactive news snapshot: UK Oil & Gas Investments, ValiRx, Kazera Global …
A glance at some of the day's highlights from the Proactive Investors newswire
ImmuPharma says pre-clinical study points to other indications for lead drug
Currently being developed to treat lupus, peptide P140 may hold the potential to treat another painful autoimmune disease
Investments and investor services
FTSE 100 closes higher as European Central Bank message cheers markets
The FTSE 100 has clawed back all of this morning's losses and some, while the ECB has unveiled plans to end its quantitative easing programme in December
Archive
Proactive news snapshot: ImmuPharma, Advanced Oncotherapy, Mosman Oil And Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
88 Energy surges after confirming it on track to restart well-testing at Icewine-2
A look at today's major risers and fallers in London, including Advanced Oncotherapy, Tekcapital, IDOX, RedstoneConnect, Dixons Carphone and Renold
ImmuPharma shares jump as chairman upbeat after phase III data review for flagship drug
ImmuPharma chairman Tim McCarthy said: "We continue to believe Lupuzor has the potential to bring a much needed treatment to Lupus sufferers around the world"
FTSE 100 drops 1.26% as political turmoil in Europe hits
In the current markets, the pound fell 0.49% against the US dollar at 1.1472..
ImmuPharma chairman and chief executive upbeat on Lupuzor; industry interest remains strong
The pair said the debate around the company's flagship drug is far more 'nuanced' than the top-line data might suggest, which explains why potential licensing partners are keen to continue talking to management
Archive
Small Cap Movers: No reason for the jump, but Indian online fashion retail Koovs still the week’s biggest riser
A look back at some of the more interesting from the junior market this week
CRH shares up as UK tarmac owner says it could float ist US division
A look at some of the highlight movers, up and down, in London
ImmuPharma drug needs further analysis; it could still have a role in treating lupus – City analyst
“We need to see more data,” said Northland Capital's Vadim Alexandre. “There is a major unmet medical"
Archive
Proactive news snapshot: PowerHouse Energy, Tertiary Minerals, SkinBioTherapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire
Ascent Resources climbs as formal sale process started after producing revenues in 2017
Some of the top news-driven risers in London at 3.45pm ...
ImmuPharma sees "significant opportunity" for lupus drug after phase III trial readout
The company revealed there had been "expressions of interest" in its lupus programme which it will explore
FTSE 100 closes higher as Wall Street surges; sterling eases
FTSE 100 closed higher, as did it mid-cap cousin, FTSE 250
Archive
Proactive news snapshot: LoopUp Group, Gfinity , Collagen Solutions …
A glance at some of the day's highlights from the Proactive Investors newswire
G4S higher as HSBC ups to ‘hold’ from ‘reduce’, with increased target price, citing valuation grounds
A look at some of the biggest risers and fallers in London on Wednesday
FTSE 100 consolidates gains to close higher but miners weigh
The UK blue-chip index finished over 44 points higher at 7,044, but big miners tempered gains
Archive
Proactive news snapshot: UK Oil & Gas, ImmuPharma, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Nighthawk Energy shares drop as production declines
A look at some of the biggest risers and fallers in London on Friday
ImmuPharma passes significant milestone; expects top line phase III data on flagship drug by the middle of next month
Chairman Tim McCarthy said: "With the continued robust safety record of Lupuzor achieved over this trial, we look forward with confidence to reporting top line results in the near future"
FTSE 100 closes down on trade war concerns as market awaits Brexit transition deal approval
Will EU leaders approve the Brexit transition deal reached between Michel Barnier and David Davis?
Archive
Proactive news snapshot: Scancell Holdings, Mosman Oil And Gas, InnovaDerma …
A glance at some of the day's highlights from the Proactive Investors newswire
LiDCO shares fall after saying it expects 2017 loss
A look at some of today's top risers and fallers in London today
Investments and investor services
FTSE 100 closes up, boosted by mining stocks and as pound strengthens against the dollar
The UK's blue-chip index closes up 20.84 points to 7,234.81
Archive
Proactive news snapshot: Empresaria Group, Directa Plus, ImmuPharma …
A glance at some of the day's highlights from the Proactive Investors newswire
Empresaria surges after a reassuring trading statement
Premaitha is given a fillip by permission to appeal against High Court's decision on patent dispute
ImmuPharma says it received strong institutional backing for £10mln City fundraiser
The cash, raised by issuing shares at 144p each, will support future investment in the P140 peptide platform
Investments and investor services
FTSE 100 closes in the red as sterling booms
“If he intended it, Treasury Secretary Steven Mnuchin has done a first class job of whacking the dollar,” declared Neil Wilson at ETX Capital. .
Archive
Proactive news snapshot: Galantas Gold, Challenger Acquisitions, Kefi Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Rio Tinto and Glencore rise on Chinese stats
A look at some of the top risers and fallers in London today.
ImmuPharma completes phase III Lupuzor study; on track to publish top-line data this quarter
The last of the 200 patients has had their final assessment and the data is now being processed and analysed
Investments and investor services
FTSE 100 extends losing streak to four days; ABF top loser
The FTSE 100 closed lower on Thursday as there was no clear direction across global equities
Archive
Proactive news snapshot: Summit Therapeutics, ImmuPharma, Corero Network Security
A glance at some of the day's highlights from the Proactive Investors newswire
Proton Power Systems shares steer higher as it appoints new chairman
A look at some of the biggest risers and fallers in London on Thursday
ImmuPharma says last patient dosed in Phase III clinical trial of lupus treatment, Lupuzor™
ImmuPharma’s chairman, Tim McCarthy, said: "Importantly we continue to see robust safety and we look forward with continued confidence to reporting top line results of the study in Q1 2018"
Investments and investor services
FTSE 100 closes above 7,600 as Santa rally kicks in
The FTSE 100 index closed up 78 points at 7,603, just off the all time high
Archive
Proactive news snapshot: European Metals Holdings, Amphion Innovations, ImmuPharma
A glance at some of the day's highlights from the Proactive Investors newswire
Telit Communications shares fall as it slams report on FCA probe
A look at some of the top risers and fallers in London today
ImmuPharma phase III clinical trial remains on track; over half the patients have now completed the study
In all, 116 of the 200 patients with the life-threatening auto-immune disease have been through the 52-week process looking at the efficacy of Lupuzor